297 related articles for article (PubMed ID: 15214742)
21. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
[TBL] [Abstract][Full Text] [Related]
22. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
[TBL] [Abstract][Full Text] [Related]
23. Preterm infants with patent ductus arteriosus: treatment with an enteral preparation of indomethacin.
So LY; Fok TF; Sung RY; Ho JK
Ann Trop Paediatr; 1992; 12(4):403-8. PubMed ID: 1283670
[TBL] [Abstract][Full Text] [Related]
24. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
[TBL] [Abstract][Full Text] [Related]
26. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
Lilien LD; Srinivasan G; Yeh TF; Pildes RS
Pediatr Pharmacol (New York); 1985; 5(1):73-7. PubMed ID: 3887313
[TBL] [Abstract][Full Text] [Related]
27. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
[TBL] [Abstract][Full Text] [Related]
28. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
[TBL] [Abstract][Full Text] [Related]
30. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
Leonhardt A; Strehl R; Barth H; Seyberth HW
Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
[TBL] [Abstract][Full Text] [Related]
31. The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters.
Tschuppert S; Doell C; Arlettaz-Mieth R; Baenziger O; Rousson V; Balmer C; Prêtre R; Dodge-Khatami A
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):78-82. PubMed ID: 18179922
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic indomethacin: factors determining permanent ductus arteriosus closure.
Narayanan M; Cooper B; Weiss H; Clyman RI
J Pediatr; 2000 Mar; 136(3):330-7. PubMed ID: 10700689
[TBL] [Abstract][Full Text] [Related]
33. A preliminary study on pharmacokinetics of oral indomethacin in premature infants in north India.
Sharma PK; Garg SK; Narang A
Indian J Med Res; 2003 Apr; 117():164-9. PubMed ID: 14604305
[TBL] [Abstract][Full Text] [Related]
34. [Renal effects of prolonged indomethacin therapy in premature infants].
Gouyon JB; Chouchane M; Françoise M
Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
[TBL] [Abstract][Full Text] [Related]
35. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
[TBL] [Abstract][Full Text] [Related]
36. The use of ibuprofen in neonates in the treatment of patent ductus arteriosus.
Van Overmeire B
Int J Clin Pract Suppl; 2003 Apr; (135):23-7. PubMed ID: 12723743
[TBL] [Abstract][Full Text] [Related]
37. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
Laughon M; Bose C; Clark R
J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
[TBL] [Abstract][Full Text] [Related]
38. Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants.
Pourarian Sh; Pishva N; Madani A; Rastegari M
East Mediterr Health J; 2008; 14(2):360-5. PubMed ID: 18561728
[TBL] [Abstract][Full Text] [Related]
39. Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.
Erdeve O; Yurttutan S; Altug N; Ozdemir R; Gokmen T; Dilmen U; Oguz SS; Uras N
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F279-83. PubMed ID: 22147286
[TBL] [Abstract][Full Text] [Related]
40. Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study.
Aly H; Lotfy W; Badrawi N; Ghawas M; Abdel-Meguid IE; Hammad TA
Am J Perinatol; 2007 May; 24(5):267-70. PubMed ID: 17484080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
